Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Operating Margin (2016 - 2026)

Ironwood Pharmaceuticals' Operating Margin history spans 16 years, with the latest figure at 161.38% for Q4 2025.

  • On a quarterly basis, Operating Margin fell 19616.0% to 161.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 4.97%, a 2153.0% decrease, with the full-year FY2025 number at 4.97%, down 2153.0% from a year prior.
  • Operating Margin hit 161.38% in Q4 2025 for Ironwood Pharmaceuticals, down from 61.84% in the prior quarter.
  • Over the last five years, Operating Margin for IRWD hit a ceiling of 666.87% in Q4 2023 and a floor of 1008.68% in Q2 2023.
  • Historically, Operating Margin has averaged 2.19% across 5 years, with a median of 52.13% in 2021.
  • Biggest five-year swings in Operating Margin: crashed -106592bps in 2023 and later soared 103514bps in 2024.
  • Tracing IRWD's Operating Margin over 5 years: stood at 114.0% in 2021, then surged by 156bps to 63.77% in 2022, then surged by 946bps to 666.87% in 2023, then plummeted by -95bps to 34.78% in 2024, then tumbled by -564bps to 161.38% in 2025.
  • Business Quant data shows Operating Margin for IRWD at 161.38% in Q4 2025, 61.84% in Q3 2025, and 53.17% in Q2 2025.